Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATE

7 Apr 2010 07:00

RNS Number : 7878J
ViaLogy PLC
07 April 2010
 



VIALOGY PLC ("VIALOGY" OR "THE COMPANY")

TRADING UPDATE

 

London, April 7, 2010. ViaLogy (LSE: VIY). The board of ViaLogy announces that the fiscal year ending March 31, 2010, marks a year of strong performance highlighted by the successful introduction of QuantumRD seismic analysis and reservoir characterization technology to the hydrocarbon energy market. ViaLogy ends the year with 12 clients under contract, including two key industry independent E&P firms, and a strong sales pipeline which should produce additional high quality Exploration and Production company customers in the coming months. The five successfully completed wells have demonstrated the ability of QuantumRD to locate productive hydrocarbon deposits in a variety of formations.ViaLogy's strategy going forward is to work closely with clients to exercise the technology in as yet untried areas of major significance, especially to bring QuantumRD to shale gas and offshore exploration plays. ViaLogy's work for contracted clients has produced an inventory contingent backlog of over 60 probable future wells to be drilled at locations recommended by ViaLogy. The Company stresses that the ultimate decision to drill, drilling schedules, and locations are dependent upon clients' operational plans, as are business decisions about the timing of hydrocarbon extraction.

The five successful well completions have been at widely separated locations in Texas ranging from 3,000 ft to 12,000 ft in depth. These targeted structural and stratigraphic formations include carbonates, vugs, clastic sediments and channel sands. The deliverables provided analysis of formation porosity, lithology and fluid presence.

ViaLogy'stechnical staff now includes experienced and industry geophysical specialists, and two to three more will join the staff in the coming months. In addition, ViaLogy will establish a Houston office to accelerate business development objectives and maintain close access to the customer base.

ViaLogy has ambitious objectives for the coming year. The focus will be on additional strong customers and repeat business, further establishing the Company's business model where payment is received through substantial up-front service fees and a share of income from successful wells. It should be emphasized that while QuantumRD - based on proprietary active signal processing technology that uniquely exploits signal spectrum and associated noise to extract more, and more precise, information from seismic data - will not prove successful in 100 per cent. of cases, it should significantly de-risk exploration as compared with current industry methods.

The coming months should see drilling of four to five new ViaLogy-positioned wells, some with new and some with established clients, and that number will increase over the course of the coming year. In its latest project, San Antonio-based client Atascosa is currently determining whether to do a deviated drilling completion of its Escondido well or to drill at another nearby ViaLogy designated location. Initial results indicate that the drilling process may have failed to achieve the placement accuracies set by ViaLogy, but has confirmed that QuantumRD analysis accurately located a pay zone and determined porosity. It is always up to the operator to determine if the expense of well completion is justified by the operator-estimated amount of profitably extractable oil, i.e. the standard he sets for his own operating margins. Atascosa's other two producing wells will be reworked in the coming months to bring them up to optimal production; such rework is typical and may include installation of larger pump and cement squeeze into the formations.

CEO Robert Dean said, "I'm very pleased that we've been able to achieve as much as we have during the last year. Anyone with experience will tell you unabashedly that you have to prove yourself to win acceptance in the oil industry, and that it doesn't come easily. Also, it's not academic - it's about finding oil. ViaLogy has done this in very challenging situations. We have successfully completed a significant number of QuantumRD wells, and, very significantly, our retrospective analysis showed why previous drilling efforts had produced dry holes for over 20 wells. The technology's ability to accurately and repeatably predict the presence of hydrocarbons and to estimate porosity are two of the critical variables in the high-risk exploration world. We are building our team of industry professionals and we can now look forward to a major year that brings ViaLogy to another level of industry acceptance for our pathbreaking QuantumRD."

 

For further information please contact:

 

ViaLogy plc

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Jeremy Stephenson / Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

 

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com. Except for statements of historical fact, the information presented herein constitutes forwardlooking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQQLFBBZFXBBZ
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.